SELLAS Life Sciences Group, Inc. (SLS)
9.98
-1.36
(-11.99%)
USD |
NASDAQ |
Oct 16, 16:00
10.08
+0.10
(+1.00%)
After-Hours: 20:00
SELLAS Life Sciences Group Cash and Short Term Investments (Quarterly) : 138.44M for June 30, 2026
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 138.44M |
| March 31, 2026 | 107.20M |
| December 31, 2025 | 71.89M |
| September 30, 2025 | 44.42M |
| June 30, 2025 | 25.40M |
| March 31, 2025 | 28.50M |
| December 31, 2024 | 13.99M |
| September 30, 2024 | 21.13M |
| June 30, 2024 | 9.247M |
| March 31, 2024 | 18.52M |
| December 31, 2023 | 2.63M |
| September 30, 2023 | 4.069M |
| June 30, 2023 | 13.91M |
| March 31, 2023 | 24.00M |
| December 31, 2022 | 17.22M |
| September 30, 2022 | 21.45M |
| June 30, 2022 | 27.09M |
| March 31, 2022 | 14.35M |
| December 31, 2021 | 21.46M |
| September 30, 2021 | 26.38M |
| June 30, 2021 | 30.02M |
| March 31, 2021 | 28.13M |
| December 31, 2020 | 35.40M |
| September 30, 2020 | 8.303M |
| June 30, 2020 | 3.44M |
| Date | Value |
|---|---|
| March 31, 2020 | 6.846M |
| December 31, 2019 | 7.377M |
| September 30, 2019 | 9.234M |
| June 30, 2019 | 12.86M |
| March 31, 2019 | 2.69M |
| December 31, 2018 | 5.451M |
| September 30, 2018 | 10.08M |
| June 30, 2018 | 9.995M |
| March 31, 2018 | 12.09M |
| December 31, 2017 | 12.75M |
| September 30, 2017 | 25.29M |
| June 30, 2017 | 31.67M |
| March 31, 2017 | 41.23M |
| December 31, 2016 | 36.10M |
| September 30, 2016 | 43.42M |
| June 30, 2016 | 43.99M |
| March 31, 2016 | 35.11M |
| December 31, 2015 | 30.13M |
| September 30, 2015 | 35.21M |
| June 30, 2015 | 45.48M |
| March 31, 2015 | 53.06M |
| December 31, 2014 | 23.85M |
| September 30, 2014 | 24.85M |
| June 30, 2014 | 39.36M |
| March 31, 2014 | 52.63M |
Cash and Short Term Investments Definition
Represents the sum of cash and short term investments.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Quarterly) Benchmarks
| AbbVie, Inc. | 6.569B |
| ImmunityBio, Inc. | 357.37M |
| TG Therapeutics, Inc. | 552.25M |
| Capricor Therapeutics, Inc. | 237.93M |
| Relay Therapeutics, Inc. | 910.93M |